ASSESS THE IMMUNOGENICITY OF THE HUMAN ROTAVIRUS (HRV) VACCINE AFTER RECONSTITUTION WITHOUT BUFFERING AGENT; & EVALUATE THE IMMUNOGENICITY, REACTOGENICITY & SAFETY OF THE VACCINE AFTER STORAGE FOR 7 D AT 37°C FOLLOWING 2 DOSES IN HEALTHY INFANTS: